Comparison of plasma and dry blood spots as samples for the determination of nitisinone (NTBC) by high-performance liquid chromatography–tandem mass spectrometry. Study of the stability of the samples at different temperatures
- 1 April 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 879 (11-12), 671-676
- https://doi.org/10.1016/j.jchromb.2011.01.031
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Determination of NTBC in serum samples from patients with hereditary tyrosinemia type I by capillary electrophoresisTalanta, 2010
- Identification of NTBC metabolites in urine from patients with hereditary tyrosinemia type 1 using two different mass spectrometric platforms: triple stage quadrupole and LTQ-OrbitrapRapid Communications in Mass Spectrometry, 2010
- The successful inclusion of succinylacetone as a marker of tyrosinemia type I in Tuscany newborn screening programRapid Communications in Mass Spectrometry, 2009
- Clinical practiceEuropean Journal of Pediatrics, 2009
- Liquid chromatography tandem mass spectrometry method for the quantitation of NTBC (2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione) in plasma of tyrosinemia type 1 patientsJournal of Chromatography B, 2009
- The genetic tyrosinemiasSeminars in Medical Genetics, Part C of the American Journal of Medical Genetics, 2006
- Nitisinone in the Treatment of Hereditary Tyrosinaemia Type 1Drugs, 2006
- Pharmacokinetics and pharmacodynamics of NTBC (2‐(2‐nitro‐4‐fluoromethylbenzoyl)‐1,3‐cyclohexanedione) and mesotrione, inhibitors of 4‐hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteersBritish Journal of Clinical Pharmacology, 2001
- Determination of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in plasma by direct injection into a coupled column liquid chromatographic systemJournal of Chromatography B: Biomedical Sciences and Applications, 1999
- Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseThe Lancet, 1992